Halneuron Phase 2b: PTRS forecast in neuropathic pain
A Gosset PTRS forecast ahead of Halneuron’s Phase 2b results in chemotherapy-induced neuropathic pain, with comparable trials, clinical evidence and forecast uncertainty.
Published · Updated
The interactive report includes the evidence and sources behind this assessment.